PHILADELPHIA PHARMACEEUTICALS
To: Jordan Securities Commission, | ﺔﻴﻟﺎﻤﻟﺍ ﻕﺍﺭﻭﻻﺍ ﺔﺌﻴﻫ ﺓﺩﺎﺴﻟﺍ | |
Amman Stock Exchange | ﻥﺎﻤﻋ ﺔﺻﺭﻮﺑ ﺓﺩﺎﺴﻟﺍ | |
Company's Name: PHILADELPHIA PHARMACEEUTICALS | ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ :ﺔﻛﺮﺸﻟﺍ ﻢﺳﺍ | |
Date: 17-04-2023 04:16:55 PM | PM 04:16:55 2023-04-17 :ﺦﻳﺭﺎﺘﻟﺍ | |
Subject: The Resolutions Of The General Assembly | ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺞﺋﺎﺘﻧ :ﻉﻮﺿﻮﻤﻟﺍ | |
Meeting | ||
The Ordinary General Assembly Meeting of | ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ 16:00 ﻰﻠﻋ 2023-04-17 ﺔﻋﺎﺴﻟﺍ َﺪﻘُﻋ | |
PHILADELPHIA PHARMACEEUTICALS was held on 16:00 | ﺐﺋﺎﺳﻭ ﻲﻓ ﻚﻟﺫﻭ.ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ ﺔﻛﺮﺸﻟ ﺔﻳﺩﺎﻌﻟﺍ | |
On 17-04-2023 at Zoom meeting, the shareholders | ﺭﻮﻀﺣ ﺔﺒﺴﻨﺑﻭ (ﻡﻭﻭﺯ ﺞﻣﺎﻧﺮﺑ) ﻲﻧﻭﺮﺘﻜﻟﻻﺍﻭ ﺐﺋﺮﻤﻟﺍ ﻝﺎﺼﺗﻻﺍ | |
participation in the Assembly Meeting was 94.01% | %94.01 | |
The following decisions were adopted at the Meeting:- | -:ﺔﻴﻟﺎﺘﻟﺍ ﺕﺍﺭﺍﺮﻘﻟﺍ ﺫﺎﺨﺗﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻝﻼﺧ ﻢﺗ | |
Subject: Approving the minutes of the previous year | ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺮﻀﺤﻣ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ | |
Ordinary General Assembly Meeting | ﻖﺑﺎﺴﻟﺍ | |
Approving the minutes of the previous year Ordinary | ﻖﺑﺎﺴﻟﺍ ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺮﻀﺤﻣ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ | |
General Assembly Meeting which was held on 27-04- | 2022-04-27 ﺦﻳﺭﺎﺘﺑ ﺪﻘﻌﻨﻤﻟﺍﻭ | |
2022 | ||
Subject: Approving The Report of the Board of Directors | ﻝﺎﻤﻋﺍ ﻦﻋ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ | |
on the activities of the Company, for the year ended on | ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ | |
specified date | ||
Approving The Report of the Board of Directors on the | ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ ﻝﺎﻤﻋﺍ ﻦﻋ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ | |
activities of the Company, for the year ended on 31-12- | 2022-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ | |
2022 | ||
Subject: Approving the Report of the Company's auditors | ﻦﻋ ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ | |
on its financial statements | ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ | |
Approving the Report of the Company's auditors on its | ﺕﺎﻧﺎﻴﺒﻟﺍ ﻦﻋ ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ | |
financial statements, for the year ended on 31-12-2022 | 2022-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ | |
Subject: Approving the Financial Statements for the year | ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ | |
ended on | ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ | |
Approving the Financial Statements for the year ended on | -31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ | |
31-12-2022 | 2022-12 | |
Subject: Approving of the Board of Director's proposal to | ﻊﻓﺪﻟﺎﺑ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺡﺍﺮﺘﻗﺍ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ | |
pay |
Approving of the Board of Director's proposal to pay 6%
ﻰﻠﻋ ﺡﺎﺑﺭﺃ ﻊﻳﺯﻮﺗ ﻥﺎﺸﺑ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺡﺮﺘﻘﻣ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ
Page 1 of 2
PHILADELPHIA PHARMACEEUTICALS
as cash dividends to the shareholders and distributing 0% | ﻝﺎﻤﻟﺍ ﺱﺍﺭ ﻦﻣ 6% ﺔﻴﺴﻨﺑ ﺔﻳﺪﻘﻧ ﺡﺎﺑﺭﺍ ﻦﻋ ﺓﺭﺎﺒﻋ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ |
as bonus shares | ﻝﺎﻤﻟﺍ ﺱﺍﺭ ﻦﻣ 0% ﺔﻴﺴﻨﺑ ﺔﻴﻧﺎﺠﻣ ﻢﻬﺳﺍ ﻊﻳﺯﻮﺗﻭ |
Subject: Discharging the board's members from their | ﻦﻋ ﺔﻴﻟﻭﺆﺴﻤﻟﺍ ﻦﻣ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺀﺎﻀﻋﺃ ﺔﻣﺫ ﺀﺍﺮﺑﺍ :ﻉﻮﺿﻮﻤﻟﺍ |
liabilities in respect of the financial year ended | ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻨﺴﻟﺍ ﻝﻼﺧ ﻢﻬﺗﺎﻓﺮﺼﺗ |
Discharging the board's members from their liabilities in | ﻢﻬﺗﺎﻓﺮﺼﺗ ﻦﻋ ﺔﻴﻟﻭﺆﺴﻤﻟﺍ ﻦﻣ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺀﺎﻀﻋﺃ ﺔﻣﺫ ﺀﺍﺮﺑﺍ |
respect of the financial year ended 31-12-2022 | 2022-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻨﺴﻟﺍ ﻝﻼﺧ |
Subject: Approving the appointment / reappointment of the | ﺕﺎﺑﺎﺴﺤﻟﺍ ﻲﻘﻗﺪﻣ ﻦﻴﻴﻌﺗ ﺓﺩﺎﻋﺇ / ﻦﻴﻴﻌﺗ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ |
auditors for the financial year and authorizing the board of | ﻢﻬﺑﺎﻌﺗﺃ ﺪﻳﺪﺤﺘﻟ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺾﻳﻮﻔﺗﻭ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ |
directors to determine their fees | |
Approving the appointment/reappointment of the auditors | ﺓﺩﺎﺴﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﻦﻴﻴﻌﺗ ﺓﺩﺎﻋﺍ ﻭﺍ/ ﻦﻴﻴﻌﺗ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ |
International Professional Bureau for the financial year 31- | ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻖﻴﻗﺪﺘﻟ International Professional Bureau |
12-2023.And authorizing the board of directors to | ﺪﻳﺪﺤﺘﺑ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺾﻳﻮﻔﺗ ﻭ 2023-12-31 ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ |
determine their fees | ﻢﻬﺑﺎﻌﺗﺍ |
Subject: Any other matters which the General Assembly | ﻲﻓ ﺎﻬﺟﺍﺭﺩﻹ ﺔﻣﺎﻌﻟﺍ ﺔﻴﻌﻤﺠﻟﺍ ﺎﻬﺣﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﻱﺃ :ﻉﻮﺿﻮﻤﻟﺍ |
proposes to include in the agenda | ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ |
Any other matter which the General Assembly proposes to | ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻲﻓ ﺎﻬﺟﺍﺭﺩﺇ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﺡﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﻱﺃ |
include in the agenda, and are within the work scope of the | ﻥﺃ ﻰﻠﻋ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻠﻟ ﻱﺩﺎﻌﻟﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻝﺎﻤﻋﺃ ﻕﺎﻄﻧ ﻲﻓ ﻞﺧﺪﻳﻭ |
General Assembly in its ordinary meetings, provided that | ﻦﻣ ﺩﺪﻋ ﺔﻘﻓﺍﻮﻤﺑ ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻲﻓ ﺡﺍﺮﺘﻗﻻﺍ ﺍﺬﻫ ﺝﺍﺭﺩﺃ ﻥﺮﺘﻘﻳ |
such a proposal is approved by shareholders representing | ﻲﻓ ﺔﻠﺜﻤﻤﻟﺍ ﻢﻬﺳﻷﺍ ﻦﻣ (%10) ﻦﻋ ﻞﻘﻳ ﻻ ﺎﻣ ﻥﻮﻠﺜﻤﻳ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ |
not less than 10% of the shares represented in the meeting | ﻉﺎﻤﺘﺟﻻﺍ |
ﻯﺮﺧﺍ ﺕﺎﺣﺮﺘﻘﻣ ﺪﺟﻮﻳ ﻻ | ﻯﺮﺧﺍ ﺕﺎﺣﺮﺘﻘﻣ ﺪﺟﻮﻳ ﻻ |
Please accept our sincere thanks and appreciation. | .ﻡﺍﺮﺘﺣﻻﺍ ﻖﺋﺎﻓ ﻝﻮﺒﻘﺑ ﺍﻮﻠﻀﻔﺗﻭ |
Chairman of Board of Directors | ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺲﻴﺋﺭ |
User Name: Belal Salameh | Belal Salameh :ﻡﺪﺨﺘﺴﻤﻟﺍ ﻢﺳﺍ |
Page 2 of 2
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Philadelphia Pharmaceuticals Industry Co. PSC published this content on 18 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 April 2023 06:32:09 UTC.